United States: Mixed And Matched Hip Components Equal Express Preemption

Last Updated: August 4 2016
Article by Steven Boranian

If a surgeon combines a PMA device with a 510k device, what does that do to federal preemption? We ask this question because one of the more fascinating aspects of the medical device world is modularity.  We have heard of modular furniture, modular homes, modular computers, and modular hamster cages—collections of components that can be matched together in different ways to form the desired end result.  The highest and best use of various components could be different for each user, depending on his or her particular needs and vision.  After all, why should two different families own the same three-seat sofa when one would prefer four seats, with a recliner, and perhaps a built-in cooler, and maybe add the matching foot stool?

When you look at it that way, many medical devices (and particularly orthopedic devices) would have to be modular to some extent to offer the greatest benefit to patients. A defining principle of healthcare—and the laws that govern it—is that different patients have different needs that require a physician's best judgment and exercise of discretion.  That was the situation in Nagel v. Smith & Nephew, Inc., No. 3:15-cv-00927, 2016 U.S. Dist. LEXIS 98408 (D. Conn. July 28, 2016).  In Nagel, a surgeon treated his patient with a hip replacement system.  But instead of using the plastic cup liner that came with the system, the surgeon elected (with his patient's consent) to use a metal liner from a similar system made by the same manufacturer, thus forming a "metal on metal" system.

The fascinating part arose because the FDA cleared the hip system under the 510k process as substantially equivalent to a predicate device. But the metal liner was approved under the FDA's rigorous premarket approval process.  Faithful readers know where this is headed—express preemption, which is strongest when applied to PMA devices like the metal liner.

Turning back then to our introductory question, what do we do with an implanted device with "mixed levels of approval"?  The short answer is that the plaintiffs' claims were all preempted, even though significant components used to treat the patient were 510k products.  Here is how the court came to that result.

The court first walked through the now-familiar dance between express and implied preemption. On the one hand, the FDCA expressly preempts any state law requirement that is different from or in addition to federal requirements. See Section 360k(a).  Thus, when suing over a PMA device, a plaintiff must allege the breach of a state-law duty that is the same as federal requirements—the so-called parallel claim exception.  On the other hand, the plaintiff's claim must not rely only on a requirement already imposed under the FDCA, or else the claim is impliedly preempted under Buckman.  That's the "narrow gap" through which a plaintiff must navigate. Id. at **10-11.

The key of course is that the "narrow gap" closes down on the plaintiff only when dealing with a PMA device (with exceptions that we won't cover here). When dealing with "mixed levels of approval," different courts have gone different ways. Id. at **11-12.  But the court in Nagel decided that express preemption applied:

I am persuaded by the initial line of cases that applies the MDA's express preemption clause to claims involving device components subject to mixed levels of approval, particularly in the context of the allegations that are present in this case, which focus on harm allegedly caused either independently by the PMA-approved R3 metal liner, or by the R3 metal liner's interaction with the R3 system (and as distinct from any harm stemming from the § 510(k)-approved R3 system not related to the PMA-approved R3 metal liner). Because the FDCA does not prohibit off-label use of a component within a PMA-approved device in another medical device, I conclude that a manufacturer should not lose the protections of express preemption under § 360k(a) because of a surgeon's permissible choice to use the PMA-approved component in a § 510(k)-approved device, even if the interaction of the two components causes problems.

Id. at **12-13. Let's unpack that a little.  It's basically a two-step analysis.  The court first reasoned that the harm allegedly flowed from the PMA-approved metal liner, either independently or from its interaction with other components.  On this score, the court took care to distinguish (without deciding) a situation where the alleged harm was not related to the PMA device. Id.

Second, the court explained the policy behind its decision: The law does not prohibit off-label use, which could include the use of a PMA device with another system for which it was not approved.  According to the court, a surgeon's "permissible choice" to use a PMA-approved component within a 510k cleared system should not undermine the express preemption protection to which the product's manufacturer would normally be entitled. Id. at *13.  The FDCA defines "device" to include "any component, part, or accessory." Id. at *14 (citing 21 U.S.C. § 321(h).

So express preemption applied, which led to a claim-by-claim analysis of the plaintiffs' complaint. On strict product liability and failure to warn, the plaintiffs did not allege facts constituting the violation of any FDA requirement, leaving them no basis for a "parallel claim." Id. at **16-20.  They alleged only that metal-on-metal hip replacement systems had higher-than-desired revision rates, not that the design or manufacture of the devices violated federal requirements. Id. at **17-18.  On failure to warn, the plaintiffs alleged that the manufacturer had failed to comply with the FDA's requirements for adverse event reporting (an apparent attempt to echo the Ninth Circuit's wrongly decided Stengel v. Medtronic opinion), but they alleged no facts to back up that allegation, nor facts that any alleged failure to report caused the plaintiffs' injury. Id. at **19-20.

There was no parallel claim for misrepresentation based on off-label promotion because "[t]here is no federal claim for off-label marketing, so no state law claim can survive." Id. at *21.  Plus, even if there were a federal claim for false and misleading off-labeling marketing, the plaintiffs had not sufficiently alleged facts that the marketing actually was false or misleading. Id. at **21-22.  The negligence and implied warranty claims fell for similar reasons—they sought to impose requirements in addition to federal law—testing requirements, reporting requirements, manufacturing requirements, and the like. Id. at **22-24.  None of those could support "parallel claims."

The final blow was an order denying leave to amend as futile. The plaintiffs had already taken one opportunity to amend, and they had "not indicated what changes [they] would make to survive a future challenge . . ., but rather steadfastly assert[ ] that [their] first amended complaint is sufficient."  In an environment in which we find courts granting leave to amend all too liberally, the court's reasons here is sound.  Plaintiffs already had two chances, and having stood on their amended complaint, their journey was over.

This article is presented for informational purposes only and is not intended to constitute legal advice.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions